We are live on ! Find out more
HP

HealthInvest Partners Portfolio holdings

AUM $372M
1-Year Est. Return 59.89%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$137M
AUM Growth
-$40.5M
Cap. Flow
-$42.1M
Cap. Flow %
-30.71%
Top 10 Hldgs %
79.55%
Holding
19
New
–
Increased
5
Reduced
11
Closed
3

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$4.84M
2
AIQ
Alliance Healthcare Services
AIQ
+$1.09M
3
AORT icon
Artivion
AORT
+$246K
4
NOTV
Inotiv
NOTV
+$246K
5
ICCC icon
ImmuCell
ICCC
+$126K

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$9.93M
2
HOLX
Hologic
HOLX
+$8.16M
3
ESRX
Express Scripts Holding Company
ESRX
+$7.45M
4
CRL icon
Charles River Laboratories
CRL
+$6.68M
5
MGLN
Magellan Health Services, Inc.
MGLN
+$4.44M

Sector Composition

Rank Sector Weight
1 Healthcare 76.84%
2 Financials 16.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AET
1
DELISTED
Aetna Inc
AET
$15.5M 11.28%
190,900
+59,500
+45% +$4.84M
ELV icon
2
Elevance Health
ELV
$81.6B
$15.5M 11.27%
129,200
-16,600
-11% -$1.9M
AIQ
3
DELISTED
Alliance Healthcare Services
AIQ
$12M 8.74%
529,818
+39,440
+8% +$1.09M
THOR
4
DELISTED
THORATEC CORPORATION
THOR
$9.79M 7.14%
366,066
-74,300
-17% -$2.11M
CAH icon
5
Cardinal Health
CAH
$53.9B
$9.76M 7.12%
130,200
-5,500
-4% -$400K
CRL icon
6
Charles River Laboratories
CRL
$11.3B
$9.64M 7.03%
161,320
-116,693
-42% -$6.68M
GILD icon
7
Gilead Sciences
GILD
$162B
$9.51M 6.93%
89,300
-29,200
-25% -$2.86M
CFN
8
DELISTED
CAREFUSION CORPORATION
CFN
$9.5M 6.93%
209,900
-9,700
-4% -$437K
MGLN
9
DELISTED
Magellan Health Services, Inc.
MGLN
$9.02M 6.58%
164,792
-77,400
-32% -$4.44M
MDT icon
10
Medtronic
MDT
$110B
$8.96M 6.53%
144,600
-15,300
-10% -$973K
LPNT
11
DELISTED
LifePoint Health, Inc.
LPNT
$8.86M 6.46%
128,100
-38,000
-23% -$2.67M
SKH
12
DELISTED
SKILLED HEALTHCARE GROUP, INC. CLASS A COM STK
SKH
$7.22M 5.27%
1,094,369
-18,516
-2% -$121K
GTS
13
DELISTED
Triple-S Management Corporation
GTS
$6.5M 4.74%
343,551
-29,250
-8% -$513K
AORT icon
14
Artivion
AORT
$1.31B
$4.33M 3.16%
438,364
+25,000
+6% +$246K
NOTV
15
DELISTED
Inotiv
NOTV
$601K 0.44%
260,366
+105,269
+68% +$246K
ICCC icon
16
ImmuCell
ICCC
$101M
$524K 0.38%
105,350
+26,873
+34% +$126K
HOLX
17
DELISTED
Hologic
HOLX
– –
-321,920
Closed -$8.16M
HRC
18
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-239,200
Closed -$9.93M
ESRX
19
DELISTED
Express Scripts Holding Company
ESRX
– –
-107,500
Closed -$7.45M

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
AWA
Acumen Wealth Advisors Chattanooga, Tennessee $372M AUM
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
SC
Saybrook Capital Winston Salem, North Carolina $371M AUM 13.23% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

HealthInvest Partners's Q3 2014 Portfolio in Review

As of Q3 2014, HealthInvest Partners held 19 positions worth $137M, down 23% from $178M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

HealthInvest Partners withdrew a net $42.1M in Q3 2014, closing 3 positions and reducing 11 holdings. Its most notable exit was HILL-ROM HOLDINGS, INC., an estimated $9.93M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 76% a quarter earlier, followed by Financials.

Against the trend, HealthInvest Partners added an estimated $4.84M to Aetna Inc.

  • HealthInvest Partners added most to Aetna Inc in Q3 2014, an estimated $4.84M increase.
  • HealthInvest Partners's biggest Q3 2014 reduction was Charles River Laboratories, cutting an estimated $6.68M.
  • HealthInvest Partners fully exited HILL-ROM HOLDINGS, INC. in Q3 2014, selling an estimated $9.93M.
  • HealthInvest Partners's ten largest holdings make up 80% of its $137M portfolio in Q3 2014.
  • HealthInvest Partners opened 0 new positions and closed 3 in Q3 2014.
  • HealthInvest Partners's portfolio value fell 23% quarter-over-quarter to $137M.

Based on HealthInvest Partners's 13F filing for Q3 2014, filed 14 Oct 2014.